New MRI Technology Spots Lung Cancer and Hidden Spread Earlier
Summary
Lung cancer is often discovered only after it has spread. Detecting tumors and metastases at much earlier stages could significantly improve treatment options and outcomes.
What Happened
Researchers led by Georgia State University have developed a new protein-based MRI contrast agent called hProCA32.Collagen that can detect lung cancer tumors and hidden metastases as small as 1 millimeter, earlier than conventional imaging methods. The technology targets collagen type I, a protein found at elevated levels in aggressive lung tumors and metastatic lesions.
Why It Matters
Lung cancer is often discovered only after it has spread. Detecting tumors and metastases at much earlier stages could significantly improve treatment options and outcomes.
Key Takeaways
n preclinical studies, the MRI agent identified tiny tumors and cancer spread in organs such as the lungs, adrenal glands, and kidneys without exposing patients to radiation. Researchers believe the technology could improve early diagnosis, help predict how aggressive a cancer is, guide treatment decisions, and potentially reduce the need for invasive biopsies.